Alan Menter, MD
Dr. Menter is a world-renowned, Board-Certified dermatologist and leader on psoriasis. He founded the International Psoriasis Council in 2004, as well as co-authored a groundbreaking study that identified the first gene involved in the development of psoriasis. Dr. Menter started the psoriasis center at Baylor University Medical Center (BUMC) and was its medical director from 1979 until 1999. Since 1994, he has been chairman of the Division of Dermatology at BUMC and elected one of the top doctors in the USA (1994–Present). He has been on the faculty of the University of Texas Southwestern Medical School (UT Southwestern) since arriving in Dallas and has been clinical professor of dermatology there since 1996. Dr. Menter has written over 350 articles, 5 books, and 21 book chapters in peer reviewed medical publications and has an international reputation as a clinician/researcher. He has been a member of the editorial board of the Journal of the American Academy of Dermatology, the Journal of Clinical Dermatology, and Specialist Medicine-Dermatology.
Emma Guttman-Yassky, MD, PhD
Dr. Guttman-Yassky is the Vice Chair of Research in the Dermatology Department is a Professor of Dermatology & Immunology at Mount Sinai School of Medicine in New York. She is the Director of the center for Excellence in Eczema, the Occupational/Contact Dermatitis clinic, and the Director of the Laboratory of Inflammatory Skin Diseases at the Icahn School of Medicine at Mount Sinai Medical Center in New York. She earned her M.D. degree from Sackler School of Medicine at the Tel-Aviv University, and a PhD degree from the Bar-Ilan University Ramat-Gan, Israel. After obtaining her Israeli Board certification in Dermatology, she became Board-certified by the American Board of Dermatology having completed training at the Weill-Cornell Medical College, in NY. Dr. Guttman’s major clinical focus is atopic dermatitis (AD)/eczema, contact/occupational dermatitis, alopecia areata, and psoriasis. She has done groundbreaking research and published extensively on inflammatory skin diseases. Her research made paradigm-shifting discoveries on the immunologic basis of atopic dermatitis (AD) in humans, enriching the understanding of the pathophysiology of this common disorder, opening the door to new therapeutics. Dr. Guttman has developed comprehensive molecular maps of AD, defining skin differentiation and immune-circuits characterizing this disease. She has established the reversibility of the AD phenotype and defined a series of disease- and response- biomarkers that are now accelerating testing of novel immune, pathway-specific drugs in this disease. Her research is the first to identify in humans a distinct population of T-cells that independently produce IL-22, conceptualizing AD as a Th2/Th22-polarized disease. Dr. Guttman is now testing (both clinically and mechanistically) multiple targeted therapeutics for atopic dermatitis that target Th2, Th22, and Th17/IL-23 axis.
Mark G. Lebwohl, MD
Dr. Lebwohl is the Sol and Clara Kest Professor and Chair, The Kimberly and Eric J. Waldman Professor, and Chairman of The Kimberly and Eric J. Waldman, Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York. An accomplished writer and prolific contributor, Dr. Lebwohl has authored or co-authored more than 500 publications and written or edited several books, including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading textbook on dermatologic therapy, Treatment of Skin Disease. The second edition of The Skin and Systemic Disease has also recently been published. He is on the editorial boards of many dermatology journals and was the founding editor of the “Medical Pearl” section of the Journal of the American Academy of Dermatology. Dr. Lebwohl is also the founding editor of Psoriasis Forum and the Journal of Psoriasis and Psoriatic Arthritis. He is a former president of the American Academy of Dermatology (AAD) and a current member of its board of directors. He has also served as president of the Manhattan-Metropolitan Dermatological Society, State Society of Dermatology, and NY Dermatological Society. In addition, he is former chair of the Scientific Assembly Committee and former assistant editor of the Journal of the American Academy of Dermatology. Dr. Lebwohl earned his medical degree from Harvard Medical School in Boston, Massachusetts and completed his residency in dermatology at the Mount Sinai Medical Center. One of the first topical therapies approved for skin cancer and for precancerous lesions was identified by Dr. Lebwohl, and many of the systemic and topical therapies for psoriasis were studied or developed under his guidance.